Chemoinformaics analysis of 1-Decane,2, 4-dimethyl-
| Molecular Weight | 484.677 | nRot | 8 |
| Heavy Atom Molecular Weight | 440.325 | nRig | 18 |
| Exact Molecular Weight | 484.319 | nRing | 2 |
| Solubility: LogS | -4.307 | nHRing | 1 |
| Solubility: LogP | 7.497 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 83.4489 |
| nHD | 0 | BPOL | 49.3491 |
| QED | 0.227 |
| Synth | 5.689 |
| Natural Product Likeliness | 1.824 |
| NR-PPAR-gamma | 0.364 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.043 |
| HIA | 0.207 |
| CACO-2 | -4.994 |
| MDCK | 0.0000184 |
| BBB | 0.072 |
| PPB | 0.952882 |
| VDSS | 2.406 |
| FU | 0.0611677 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.398 |
| CYP2c19-inh | 0.351 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.161 |
| CYP2c9-sub | 0.117 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.03 |
| CYP3a4-inh | 0.803 |
| CYP3a4-sub | 0.905 |
| CL | 13.612 |
| T12 | 0.033 |
| hERG | 0.001 |
| Ames | 0.458 |
| ROA | 0.938 |
| SkinSen | 0.022 |
| Carcinogencity | 0.251 |
| EI | 0.076 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.541 |
| Antiviral | Yes |
| Prediction | 0.723162 |